Archive for 2008/07


Veterans With Asbestos-Related Breathing Diseases May Be Entitled To Compensation From The Federal Government, Canada

The Lung Association recommends that navy veterans who worked on ships or shipyards during the Second World War and up until the 1970s to see their doctor for an examination. These veterans may have been exposed to asbestos and may have an asbestos-related breathing disease as a result. Those who have been diagnosed with asbestos-related breathing diseases may be entitled to compensation from the federal government.
(more...)


07/28/2008 | Respiratory & Asthma | Trackback | Comments Off

European Medicines Agency Recommends Restricting The Use Of Oral Moxifloxacin-Containing Medicines

Finalising a review of the safety of moxifloxacin-containing medicines for oral use, the European Medicines Agency (EMEA) has concluded that these medicines should only be prescribed in the treatment of acute bacterial sinusitis, acute exacerbation of chronic bronchitis and community-acquired pneumonia when other antibiotics cannot be used or have failed. The Agency also recommended strengthening the warnings for oral moxifloxacin medicines.
(more...)


07/28/2008 | Respiratory & Asthma | Trackback | Comments Off

Fragrance Materials Association Assures Safety Of Fragrance Ingredients - No Contrary Evidence In Contested University Of Washington Study

A study was released by Anne Steinemann, a researcher at the University of Washington claiming fragrance ingredients contained in a selection of consumer products are potentially toxic. The fragrance materials industry has the highest concern for the safety of its products. We have a sound four-step safety testing process.
(more...)


07/28/2008 | Respiratory & Asthma - Public Health | Trackback | Comments Off

Bayer Welcomes The Proposed EMEA Labeling Changes For Moxifloxacin

Bayer is pleased to announce that today the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) proposed a labeling change for oral moxifloxacin for the treatment of Acute Exacerbations of Chronic Bronchitis (AECB), Acute Bacterial Sinusitis (ABS) and Community Acquired Pneumonia (CAP) in line with official European clinical guidelines.
(more...)


07/28/2008 | Respiratory & Asthma | Trackback | Comments Off

Smoking Among Schoolchildren At 25 Year Low, UK

Smoking among school children has fallen to its lowest level for 25 years, according to an NHS Information Centre survey published today (July 17 2008). Six per cent of pupils mostly aged 11 to 15 smoked regularly in 2007, the lowest figure recorded since the survey began in 1982. Drug and alcohol use among the same age group is also falling, according to the survey; Drug use, smoking and drinking among young people in England in 2007.
(more...)


07/28/2008 | Respiratory & Asthma - Smoking / Quit Smoking | Trackback | Comments Off

Grant Received By Heart Researchers To Study Asthma

A research grant program that encourages "thinking outside the box" will allow a team of University of Iowa investigators to apply findings from heart research to the study of asthma. Specifically, the team has received a three-year, $750,000 grant from the Strategic Program for Asthma Research, known as SPAR, to see if an enzyme known to play a role in heart failure might also affect smooth muscle cells in the airway and thus play a role in asthma.
(more...)


07/28/2008 | Respiratory & Asthma | Trackback | Comments Off

The Consequences Of Viral Infections Negatively Impacted By Cigarette Smoke

Jack Elias and colleagues, at Yale University School of Medicine, have performed new studies in mice that provide mechanistic insight into why viral infections have more severe consequences in individuals exposed to cigarette smoke than in those not exposed to cigarette smoke (e.g., influenza-infected smokers have increased mortality when compared with influenza-infected nonsmokers).
(more...)


07/27/2008 | Respiratory & Asthma - Smoking / Quit Smoking | Trackback | Comments Off

Launch Of New Interactive Non-Small Cell Lung Cancer Resource For Physicians

EPG Health Media, developers of e-communication and clinical information solutions for the health sector, today announced the launch of a new interactive Non-small Cell Lung Cancer Knowledge Centre within the web-based physician resource www.epgonline.org.
(more...)


07/27/2008 | Respiratory & Asthma | Trackback | Comments Off

Talecris Biotherapeutics Receives Orphan Drug Designation For Aerosolized Form Of Alpha1-Antitrypsin (AAT) From The European Commission

Talecris Biotherapeutics, Inc. announced today that the European Commission followed an opinion of the Committee for Orphan Medicinal Products (COMP) and has granted orphan drug designation to Talecris' alpha-1 proteinase inhibitor (human) for inhalation use in the treatment of congenital Alpha1-Antitrypsin Deficiency (also known as AAT Deficiency or Alpha-1). Currently, there are no approved aerosolized treatments available for augmentation therapy for AAT Deficiency.
(more...)


07/27/2008 | Respiratory & Asthma | Trackback | Comments Off

TB Prevention, Treatment Should Be Integrated Into HIV Treatment Programs, JAMA Study Says

Tuberculosis prevention and treatment activities should be integrated into HIV treatment programs in resource-limited settings where TB mortality is widespread and where multi-drug resistant TB is emerging to reduce deaths among people living with HIV/TB coinfection, according to a study published Wednesday in the Journal of the American Medical Association,
(more...)


07/25/2008 | Respiratory & Asthma - HIV / AIDS | Trackback | Comments Off

« Previous Entries
Next Entries »

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

- -

>-- Top of Page --<